Cart 0

MarketsandMarkets

High-Throughput Screening Market- Forecast to 2021

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Nov-16
No. Of Pages: 255

The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.
The global high-throughput screening market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. Based on technology, the high-throughput screening market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays segment is subsegmented into 2D cell culture, 3D cell culture and perfusion cell culture. 3D cell culture is further divided into scaffold-based technology (includes hydrogels and inert matrix/solid scaffolds segment) and scaffold-free technology (includes microplates, hanging-drop plates, ultra-low binding plates and others segment). The hydrogels scaffold-based technology is further subsegmented into animal-derived (includes matrigel and collagen segment), agarose/alginate and synthetic hydrogels. The other scaffold-free technology segment includes microfluidics, 3D bioreactors & magnetic levitation, and 3D bioprinting. Based on application, the HTS market is segmented into target identification, primary screening, toxicology assessment and others. The other application segment includes hospitals and clinical laboratories, food and agriculture industries, & environmental laboratories. Based on the end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries.
Geographically, North America is the largest market for high-throughput screening, followed by Europe and Asia-Pacific. However, Asia-Pacific and Latin America possess lucrative growth potential for the high-throughput screening market during the forecast period. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding.
The high-throughput screening market is fragmented in nature with the presence of many small and big firms. The major players in the high-throughput screening market include Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland), Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).
Research Coverage:
The high-throughput screening market in this report is segmented by product and service, application, technology, end user, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and trends). The study tracks and analyzes competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographical expansions, and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the high-throughput screening market
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the high-throughput screening market; high-growth regions; and market drivers, restraints, trends, and opportunities.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on portfolios offered by the top players in the global high-throughput screening market. The report analyzes the high-throughput screening market by technology, application, products and services, and end users across all the regions.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the high-throughput screening market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for high-throughput screening across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global high-throughput screening market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global high-throughput screening market

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED IN THE REPORT 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.3.1 KEY DATA FROM SECONDARY SOURCES 29
2.3.2 KEY DATA FROM PRIMARY SOURCES 30
2.3.3 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 HIGH-THROUGHPUT SCREENING: MARKET OVERVIEW 36
4.2 ASIA-PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE 37
4.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC SNAPSHOT 38
4.4 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION 39
4.5 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC MIX 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 MARKET DRIVERS 42
5.2.1.1 Growing adoption of open innovation models in pharmaceutical
and biotechnology companies 42
5.2.1.2 Rising government funding 42
5.2.1.3 Increasing R&D spending 43
5.2.1.4 Technological advancements 44
5.2.2 MARKET RESTRAINTS 45
5.2.2.1 Capital-intensive nature of HTS 45
5.2.2.2 Complexities in the field of assay development 45
5.2.3 MARKET OPPORTUNITIES 46
5.2.3.1 High growth opportunities in emerging markets 46
5.2.3.2 Growing research activities in toxicology and stem cells 46
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 PORTER’S FIVE FORCES ANALYSIS 47
6.2.1 THREAT OF NEW ENTRANTS 48
6.2.2 THREAT OF SUBSTITUTES 48
6.2.3 BARGAINING POWER OF SUPPLIERS 48
6.2.4 BARGAINING POWER OF BUYERS 48
6.2.5 COMPETITIVE RIVALRY 49
6.3 TECHNOLOGICAL TRENDS 49
6.3.1 LABEL-FREE TECHNOLOGY, AN EMERGING TREND 49
6.3.2 AUTOMATION & MINIATURIZATION OF HTS TECHNIQUES 49
6.4 HTS IN DRUG DISCOVERY PROCESS 49
7 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE 51
7.1 INTRODUCTION 52
7.2 CONSUMABLES & REAGENTS 53
7.3 INSTRUMENTS 54
7.4 SOFTWARE & SERVICES 55
8 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY 57
8.1 INTRODUCTION 58
8.2 CELL-BASED ASSAYS 59
8.2.1 2D CELL CULTURE 61
8.2.2 3D CELL CULTURE 62
8.2.2.1 Scaffold-based Technology 64
8.2.2.1.1 Hydrogels 65
8.2.2.1.1.1 Animal-derived Hydrogels 67
8.2.2.1.1.2 Alginate/Agarose 70
8.2.2.1.1.3 Synthetic Hydrogels 71
8.2.2.1.2 Inert Matrix/Solid Scaffolds 72
8.2.2.2 Scaffold-free Technology 73
8.2.2.2.1 Microplates 74
8.2.2.2.2 Hanging-drop Plates 75
8.2.2.2.3 Ultra-low Binding Plates 76
8.2.2.2.4 Other Scaffold-free Technologies 77
8.2.3 PERFUSION CELL CULTURE 78
8.3 LAB-ON-A-CHIP 80
8.4 ULTRA-HIGH-THROUGHPUT SCREENING 81
8.5 LABEL-FREE TECHNOLOGY 82
8.6 BIOINFORMATICS 83
9 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION 85
9.1 INTRODUCTION 86
9.2 TARGET IDENTIFICATION 87
9.3 PRIMARY SCREENING 88
9.4 TOXICOLOGY ASSESSMENT 89
9.5 OTHER APPLICATIONS 90
10 HIGH-THROUGHPUT SCREENING MARKET, BY END USER 92
10.1 INTRODUCTION 93
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 94
10.3 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 95
10.4 CONTRACT RESEARCH ORGANIZATIONS 96
10.5 OTHER END USERS 98
11 HIGH-THROUGHPUT SCREENING MARKET, BY REGION 99
11.1 INTRODUCTION 100
11.2 NORTH AMERICA 101
11.2.1 U.S. 108
11.2.2 CANADA 113
11.3 EUROPE 118
11.3.1 GERMANY 125
11.3.2 U.K. 130
11.3.3 FRANCE 135
11.3.4 ITALY 140
11.3.5 SPAIN 145
11.3.6 REST OF EUROPE 150
11.4 ASIA-PACIFIC 155
11.4.1 JAPAN 161
11.4.2 CHINA 166
11.4.3 INDIA 171
11.4.4 REST OF ASIA-PACIFIC 176
11.5 REST OF THE WORLD 181
11.5.1 LATIN AMERICA 185
11.5.2 MIDDLE EAST AND AFRICA 191
12 COMPETITIVE LANDSCAPE 197
12.1 INTRODUCTION 197
12.2 STRATEGIC OVERVIEW 197
12.3 MARKET SHARE ANALYSIS 198
12.4 COMPETITIVE SITUATION AND TRENDS 199
12.4.1 PRODUCT LAUNCHES AND UPGRADES 201
12.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 202
12.4.3 EXPANSIONS 203
12.4.4 ACQUISITIONS 204
12.4.5 OTHER DEVELOPMENTS 205
13 COMPANY PROFILES 206
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 INTRODUCTION 206
13.2 AGILENT TECHNOLOGIES, INC. 207
13.3 DANAHER CORPORATION 211
13.4 PERKINELMER, INC. 215
13.5 THERMO FISHER SCIENTIFIC INC. 218
13.6 AXXAM S.P.A. 221
13.7 TECAN GROUP LTD. 223
13.8 BIO-RAD LABORATORIES, INC. 226
13.9 HAMILTON COMPANY 229
13.10 SIGMA-ALDRICH CORPORATION (A DIVISION OF MERCK MILLIPORE) 231
13.11 AURORA BIOMED, INC. 234
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
14 APPENDIX 236
14.1 INSIGHTS OF INDUSTRY EXPERTS 236
14.2 DISCUSSION GUIDE 237
14.3 OTHER DEVELOPMENTS 242
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 248
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 250
14.6 AVAILABLE CUSTOMIZATIONS 250
14.7 RELATED REPORTS 251
14.8 AUTHOR DETAILS 252

* indicates required information

* indicates required information


Share this Product


More from this collection